About United Therapeutics Corporation

United Therapeutics Corporation (NASDAQ: UTHR) is a Healthcare company (Biotechnology) with a market capitalization of $24.2B. Its Maz Rating is 4.63 out of 5 (A, Strong Buy), ranked against the other companies in its sector.

Factor scores: Valuation 2.39, Growth 2.95, Profitability 4.99, Financial Health 4.94, Momentum 3.70 (as of 2026-10-16).

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

CEO

Martine A. Rothblatt

Employees

1,400

IPO date

1999-06-17